Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-26T19:05:53.444Z Has data issue: false hasContentIssue false
  • English
  • Français

Glutamate and Aspartate Do Not Modify the Ataxic Gait of Acrylamide Treated Animals

Published online by Cambridge University Press:  18 September 2015

G. De Michele ,
F.B. Jolicoeur  and
A. Barbeau
G. De Michele
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
F.B. Jolicoeur
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
A. Barbeau*
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
*
Clinical Research Institute of Montreal, 110 Pine Avenue West, Montréal, Quebec, Canada H2W 1R7
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The purpose of this experiment was to examine the effects of intraventricular injections of glutamate and aspartate on the gait of animals rendered ataxic by the administration of acrylamide. Contrary to their previously reported corrective Influence on ataxia induced by 3-acetyl pyridine, these amino acids did not modify the ataxic gait of acrylamide treated animals. This suggests that glutamate and aspartate can act in cerebellar but not in peripheral types of ataxia in animals.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 9 , Issue 2 , May 1982 , pp. 179 - 180
Copyright
Copyright © Canadian Neurological Sciences Federation 1982

References

REFERENCES

De Michele, G., Jolicoeur, F.B., Rondeau, D.B., Butterworth, R.F. and Barbeau, A. (1980) Effects of glutamate and aspartate on ataxic gait induced by 3-Acetyl-Pyridine in rats. Can. J. Neurol. Sci. 7:451–454.CrossRefGoogle Scholar
Desclin, J.C. and Escobi, J. (1974) Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methods. Brain Res. 77: 349–363.CrossRefGoogle ScholarPubMed
Gipon, L., Schotman, P., Jennekins, F.G.I, and Gispen, W.H. (1977) Description of the acrylamide syndrome in rats. Neuropath. Appl. Neurobiol. 3: 115–123.CrossRefGoogle Scholar
Jolicoeur, F.B., Rondeau, D.B., Hamel, E., Butterworth, R.F. and Barbeau, A. (1979) Measurements of ataxia and related neurological signs in the laboratory rat. Can. J. Neurol. Sci. 6: 209–215.CrossRefGoogle ScholarPubMed
Kuperman, A.S. (1958) Effects of acrylamide on the central nervous system of the cat. J. Pharmacol. Exp. Ther. 123: 180–192.Google ScholarPubMed
Spencer, P.S. and Schaumberg, H.H. (1974) A review of acrylamide neurotoxicity. Can. J. Neurol. Sci. 1: 152–169.CrossRefGoogle ScholarPubMed
Winer, B.J. (1971) Statistical principles in experimental design. New York: McGraw-Hill.Google Scholar